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Introduction
============

Clostridium perfringens (CP) bacteremia has been described as a rare and rapidly fatal disease secondary to massive hemolytic anemia, resulting in progressive multi-organ failure. The mortality rate exceeds 80% despite high-dose intravenous antibiotics and source control \[[@REF1]\]. It is commonly associated with diabetes, malignancy, and immunosuppression \[[@REF2]\]. In this report, we present a 65-year-old diabetic male with CP bacteremia which progressed into fulminant hepatic failure with subsequent fatal cerebral edema.

Case presentation
=================

A 65-year-old male with a history of diabetes mellitus and coronary artery disease presented to an outside hospital emergency department with an one-day history of abdominal pain. He was febrile to 101.3 °F with leukocytosis of 32K/µL, elevated transaminases and hyperbilirubinemia (total bilirubin of 7.8 mg/dL). The working diagnosis was cholangitis. The patient was started on broad-spectrum intravenous antibiotics, and transferred to our hospital for endoscopic retrograde cholangiopancreatogram (ERCP) and further management.

The ERCP revealed no evidence of biliary duct obstruction (Figure [1](#FIG1){ref-type="fig"}), and a non-obstructing biliary stone was found in a duodenal diverticulum associated with the major papilla (Figure [2](#FIG2){ref-type="fig"}). A computed tomography (CT) scan of the abdomen and pelvis was obtained which showed multiple hepatic abscesses containing air fluid levels involving the right hepatic lobe. These abscesses were not amenable to percutaneous drainage (Figure [3](#FIG3){ref-type="fig"}). Due to concerns of gaseous organism infection, repeat ERCP with sphincterotomy and stent placement were performed with the intention of source control. Blood culture from the outside hospital returned as Clostridium perfringens.

![The first endoscopic retrograde cholangiopancreatogram (ERCP) revealing absence of filling defect in the biliary tree (outlined area and arrow).](cureus-0009-00000001714-i01){#FIG1}

![Duodenal diverticulum containing stone.](cureus-0009-00000001714-i02){#FIG2}

![Multiple hepatic abscesses and multiple air fluid levels.](cureus-0009-00000001714-i03){#FIG3}

On hospital day four, general surgery was consulted. Repeat CT scans of the abdomen showed no worsening of the liver abscesses. However, the patient continued to decline clinically, with sepsis progressing to multi-system organ failure, requiring hemodialysis. Furthermore, he developed an altered mental status and was intubated for airway protection. Given his worsening clinical picture, the patient was taken to the operating room where he underwent open surgical debridement and drainage with ultrasound guidance. The CT scan obtained on postoperative day two demonstrated resolution of liver abscesses (Figure [4](#FIG4){ref-type="fig"}). The blood cultures obtained in our institution were negative. However, the hepatic abscess culture grew Saccharomyces cerevisiae (SC) after 10 days of incubation.

![Resolution of liver abscess status post-surgical drainage. Outline and arrow indicating area of interest.](cureus-0009-00000001714-i04){#FIG4}

On postoperative day three, the patient had a seizure episode, prompting a CT scan of the head which demonstrated cerebral edema. Magnetic resonance imaging (MRI-angiogram) of the head was done, revealing no vascular abnormality. The cerebral edema was thought to be secondary to acute liver failure. A repeat CT scan of the head, on postoperative day five revealed progressive diffuse cerebral edema with the development of obstructive hydrocephalus (Figure [5](#FIG5){ref-type="fig"}). Neurosurgery was consulted, who felt further intervention would not alleviate an impending herniation. On hospital day eleven, the patient\'s family opted for comfort care measures. He was terminally extubated, expiring shortly thereafter.

![Severe and diffuse cerebral edema with obstructive hydrocephalus.](cureus-0009-00000001714-i05){#FIG5}

Discussion
==========

Law and Lee \[[@REF3]\] reviewed 20 cases of CP bacteremia with liver abscesses from 1990 to 2012, showing a median time from admission to death of 11 hours. In contrast to those described in the literature, our patient did not have massive intravascular hemolysis, hypotension on presentation, or a rapidly fatal outcome. Although his initial blood cultures were positive for CP at outside hospital, his repeat blood cultures in our hospital were negative for organisms. This negative result could be explained by early initiation of intravenous antibiotics.

The patient's hepatic culture data was significant for the late growth of Saccharomyces cerevisiae. One case of liver abscess positive for SC was described in 1990 \[[@REF4]\]. In this review, CP was also isolated in the liver abscess culture but the blood culture was positive for Pseudomonas aeruginosa. This discordance of microorganism between blood culture and liver abscess cultures was also described in other cases of CP abscess \[[@REF5]-[@REF6]\].

It is unclear whether this patient truly had CP liver abscess because hepatic fluid failed to isolate CP. Nevertheless, he presented with clinical features of pyogenic liver abscess: fever, epigastric pain, bacteremia, and the presence of gas on liver image studies. The liver culture could be false negative for CP. There was also a case in the literature reported with positive CP blood culture with failure to isolate CP from liver abscess culture \[[@REF7]\].

We proposed that his fulminant hepatic failure was the primary event leading to his clinical outcome. This would explain the lack of CP in the liver abscess culture. The majority of fulminant liver failure are idiopathic. The hepatic cell death and necrosis, as well as the ERCP performed prior to the CT scan, could contribute to the hepatic gas shown on the CT image. The abscess formation pattern during the debridement was noted to be in the hepatic vein distribution, which has been shown to be more consistent with liver necrosis rather than a liver abscess. This could explain the patient's lack of overwhelming shock expected with CP bacteremia. To our knowledge, this is the first documented case of CP bacteremia associated with fulminant liver failure which progressed to fatal cerebral edema.

We reviewed 37 cases of CP bacteremia with associated liver abscesses reported since 1990 (Table [1](#TAB1){ref-type="table"}). These cases had an average age of 67 years (range: 42 to 84; 26 patients were male (70%), and 11 were female (30%). The most common underlying condition was diabetes (41%). There were eight patients with diabetes as the only medical co-morbidity. Ten patients (27%) had malignancy. Two (5%) had a history of transplantation for primary sclerosing cholangitis or alcohol cirrhosis who were on immunosuppressive therapy. Eight (20%) had a history of hepatobiliary pancreatic operations or procedures within two months prior the diagnosis of CP liver abscesses. Six (16%) had no underlying conditions.

###### Cases of Clostridium perfringens infection associated with gas-containing liver abscesses on image studies published since 1990.

Hb = reported hemoglobin (g/dL); WBC = white blood cell count (K-g/L); TBili = total bilirubin (mg/dL); LDH = Lactate dehydrogenase; M = male; F = female; DM = diabetes mellitus; CBD = common bile duct; CA = cancer; TACE = transarterial chemoembolization; ESRD = end-stage renal disease; HD = hemodialysis; HCC = hepatocellular carcinoma; RY HJ = Roux-en-Y hepatojejunostomy; MW = microwave; Yes-p = percutaneous drainage; Yes- O = operative drainage; BCx = blood culture; Liver Cx= Liver Culture; + = positive for Clostridium perfringens; nr = not reported or not obtained; E. coli = positive for E. coli but negative for Clostridium perfringens; -- = negative for C. perfringens; (a) = autopsy; S.c.= positive for Saccharomyces cerevisiae, negative for Clostridium perfringens. Hrs = hours; N/A = does not apply.

References mentioned in this table are available on request.

  ----- --------------------- ------ ----- ----- ------------------------------------------------ -------- ------ ------- --------- --------------- ---------- ----------- -----------------------
  No.   Author                Year   Age   Sex   Underlying Conditions(s)                         WBC      Hb     TBili   BCx       Hepatic drain   Liver Cx   Survi-val   Hrs present. to death
  1     Batge \[[@REF7]\]     1992   61    M     DM, pancreatic cancer s/p Whipple                38.2     11.6   43.9    \+        Yes -- p        --         Yes         N/A
  2     Rogstad               1993   61    M     None                                             N/A      16.7   N/A     \+        No              \+ (a)     No          3
  3     Gutierrez             1995   74    M     None                                             19.8     13.1   4.1     \+        No              \+ (a)     No          6
  4     Jones                 1996   66    F     Liver Transplant                                 11.3     11.3   4.4     \+        No              \+ (a)     No          10
  5     Eckel                 2000   65    F     CBD CA meta s/p TACE                             13       11.2   4.6     \+        Yes -- p        nr         Yes         N/A
  6     Kreidl                2002   80    M     DM, ESRD on HD                                   29       10.7   12.6    \+        No              \+ (a)     No          11
  7     Pichon                2003   42    F     Alcohol cirrhosis                                6.2      10.2   12.3    \+        No              nr         Yes         N/A
  8     Quigley               2003   73    M     Ischemic heart                                   11       14.2   4.2     nr        No              \+ (a)     No          Died at home
  9     Bergert \[[@REF5]\]   2004   58    M     Pancreatic cancer s/p Whipple 1 yr               34.1     N/A    7.7     E. coli   Yes -- p        \+         No          24
  10    Au                    2005   65    M     DM, ESRD on HD                                   25       6.2    9.4     nr        No              \+         No          72
  11    Fondran               2005   63    M     pancreatic cancer meta to liver                  N/A      N/A    N/A     \+        Yes -- O        nr         Yes         N/A
  12    Daly                  2006   80    M     DM                                               N/A      8.7    N/A     \+        No              nr         No          3
  13    Ohfani                2006   78    M     DM                                               18.6     10     1.4     \+        No              \+ (a)     No          3
  14    Loran                 2006   69    M     None                                             26       8.7    N/A     nr        No              \+ (a)     No          6
  15    Alarcon Del Agua      2009   74    M     Stroke                                           16       N/A    3.7     \+        Yes -- O        \+         Yes         N/A
  16    Merino                2009   83    F     None                                             26.5     12.2   19.6    \+        No              nr         No          72
  17    Meyns                 2009   64    M     DM, myelodysplastic syndrome                     1.5      7.2    8.3     \+        Yes -- p        \+         No          48
  18    Tabarelli             2009   65    F     pancreatic cancer s/p Whipple                    N/A      N/A    N/A     \+        Yes -- p        \+         No          120
  19    Bradly \[[@REF2]\]    2010   52    M     HCC s/p RY HJ                                    11.6     N/A    17.4    \+        No              \+ (a)     No          6
  20    Ng                    2010   61    F     DM                                               16.8     13.5   15.4    \+        Yes -- O        nr         Yes         N/A
  21    Rajendran             2010   58    M     None                                             14.6     13.3   N/A     \+        Yes -- O        \+         Yes         N/A
  22    Law \[[@REF3]\]       2012   50    F     Rectal Cancer                                    46.3     8.3    8.9     \+        Yes -- p        nr         No          168
  23    Qandeel               2012   59    F     DM, s/p cholecystectomy                          N/A      9.1    N/A     \+        Yes -- O        nr         Yes         N/A
  24    Sathiyam-oorthy       2012   65    F     DM                                               N/A      N/A    N/A     \+        Yes -- p        nr         Yes         N/A
  25    Imai                  2014   76    M     HTN                                              33.2     12.2   10.5    \+        Yes -- p        \+         No          5
  26    Kitterer              2014   71    M     Liver Transplant                                 18.5     11.2   3.7     \+        Yes -- O        nr         No          13
  27    Kurasawa              2014   65    M     DM                                               24.8     13.5   6.4     \+        No              nr         No          6
  28    Cochrane              2015   65    F     DM                                               normal   13     9.6     \+        Yes -- p        nr         Yes         N/A
  29    Eltawansy             2015   81    F     Stroke                                           22       N/A    0.4     \+        Yes -- p        \+         No          120
  30    Khan                  2015   77    M     DM, HTN                                          33       6      9.5     --        No              \+ (a)     No          7
  31    Li                    2015   71    M     HCC s/p TACE                                     11.5     11.8   18.9    \+        No              nr         Yes         N/A
  32    Rives                 2015   63    M     Colon CA meta to liver. ERCP for obs. Jaundice   21.3     N/A    7.6     \+        Yes -- p        nr         Yes         N/A
  33    Garcia                2016   65    M     DM, Chiari I                                     22.2     14.6   2.6     \+        Yes -- p        \+         Yes         N/A
  34    Hashiba               2016   82    M     DM                                               30.1     8.3    9       \+        No              nr         No          2
  35    Kyang \[[@REF6]\]     2016   84    M     gastric cancer meta to liver s/p MW ablasion     4        N/A    N/A     E. coli   Yes -- p        \+         Yes         N/A
  36    Lim                   2016   58    M     None                                             14.2     12.4   N/A     \+        No              nr         No          7.5
  37    Shen                  2017   65    M     DM                                               32       12     7.8     \+        Yes -- O        S. c.      No          264
  ----- --------------------- ------ ----- ----- ------------------------------------------------ -------- ------ ------- --------- --------------- ---------- ----------- -----------------------

The relationship of the blood and liver abscess culture results was also evaluated. CP infection was diagnosed on the basis of positive blood or liver abscess culture results, although only 13 cases (35%) had definitive concordance between the two culture results. Nine cases (25%) of positive liver abscess cultures were from the autopsy. Fifteen (41%) cases did not report or did not obtain liver abscess culture results.

The survival rate is only 37.8% among the reviewed cases. Of the 14 survivors, 12 (85%) had the liver abscesses removed. The median time from presentation to death for mortality is 10.3 hours, which is similar to the previous report of 11 hours \[[@REF3]\].

Conclusions
===========

CP bacteremia remains a rare but life-threatening disease which requires timely diagnosis, early systemic antibiotics, and source control. A timely diagnosis could be a challenge because of the time required for the blood culture result. A clinical picture of fever, epigastric pain, bacteremia, and hepatic gas-formation on imaging studies should prompt the diagnosis of CP infection. For associated liver abscesses, either percutaneous drainage or surgical drainage is acceptable. For patients who present with acute liver failure, timely referral to a transplant center is imperative to improve the chance of survival.
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